Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Ion Channels: Specialized pores on the surface of the neural membrane which allow
the passage of a particular ion.
Active Property: K+ ions are continuously being drawn out of resting neurons, so the
neuron has to actively pump K+ ions back in at the same rate. Similarly, Na+ ions are
continuously being pulled into the resting neuron, so the neuron has to actively pump Na+
out of the cell at the same rate.
Energy-consuming mechanisms in the cell's membrane actively exchange Na+ ions from
within the cell with K+ ions from outside of cell.
Sodium Potassium Pumps: Specialized mechanisms on the cell membrane which
transport Na+ ions out of the cell and K+ ions into the cell.
Transporters: Mechanisms in the membrane of a cell which actively transport ions or
molecules across the membrane.
o Voltage-Activated Ion Channels: Ion channels in the neural membrane that open and close in
response to changs in potential across the cell membrane.
When an action potential is generated, voltage-activated sodium channels open wide to
allow Na+ to flow into the neuron.
This influx of Na+ drives the potential up from -70 mV to +50 mV.
The change in potential triggers voltage-activated potassium channels which then open and
drive K+ ions out of the cell. (First by the high concentration within the cell, but at the peak
of the action potential K+ ions are driven out by the positive charge)
After about 1 ms the Na+ channels close.
o Rising Phase: Phase of the action potential marked at the beginning by the reaching of the
threshold of excitation and the end by the closing of voltage-activated sodium channels.
Sodium channels open, allowing Na+ to flow into the neuron.
Potential of the neuron changes from -70 mV to +50 mV.
Change in potential triggers the openning of potassium channels.
After about 1 ms Sodium channels close.
o Repolarization Phase: Phase of the action potential marked at the beginning by the continued
outpouring of K+ ions and the ending by the closing of the last potassium channel. The neuron
remains hyperpolarized for a time after the repolarization phase of firing an action potential.
Once repolarization has been achieved, potassium channels gradually close
Because the closing of channels occurs gradually and not all at once, the neuron remains
hyperpolarized for a short period afterwards.
o The action potential involves only those ions directly in the environment surrounding the
neuron, and the number of ions that are moved is comparatively small to the overall number of
ions both inside and outisde the neuron.
o Resting membrane potential is quickly reestablished by the random movement of ions.
o Sodium-Potassium pumps have little to do with re-establishing the equillibrium membrane
potential of -70 mV.
Refractory Periods
o Absolute Refractory Period: Brief period of about 1 to 2 ms after the initiation of an action
potential during which time it is impossible to illicit a second one.
o Relative Refractory Period: Period following directly after the absolute refractory period.
During this time it possible to fire the neuron again but only with higher-than-normal levels of
stimulation
The end of the relative refractory period is marked by the level required to fire an action
potential returning to baseline.
o Refractory periods are responsible for some neural traits.
Action potentials normally only travel along axons in one direction. Portions of an axon
over which an action potential has just traveled are left momentarily refractory, so the action
potential is unable to reverse and travel back up the axon.
Neural firing intensity is related to the level of continual stimulation. If a neuron is being
continually and strongly stimulated, it will only wait until its relative refractory period to
fire. If it is being stimulated only enough to fire at baseline, it will wait until both the
absolute and relative refractory periods are over before firing another action potential.
Intermediate stimulation produces intermediate rates of firing.
Axonal Conduction of Action Potentials
o The conduction of action potentials along an axon is different from the conduction of potential
from synapses to the axon (EPSPs and IPSPs).
o
o
o
o The entry of Ca2+ ions causes the synaptic vesicles to fuse with the membrane of the button and
consequently release their contents into the synaptic cleft.
o For many synapses an action potential causes the release of a single synaptic vesicle.
(Neuropeptides only)
o Small-molecule neurotransmitters are typically released in a pulse each time an action potential
triggers a momentary influx of Ca2+ ions.
Activation of Receptors by Neurotransmitter Molecules
o Neurotransmitter molecules produce signals in postsynaptic neurons by binding to receptors.
o Receptor: Protein that contains binding sites for only particular neurotransmitters
Neurotransmitters can only influence cells that have receptors for it.
Ligand: A molecule that binds to another molecule; neurotransmitters are ligands of their
receptors;
Most neurotransmitters bind to several different types of receptors.
Receptor Subtypes: Different types of receptors to which a particular neurotransmitter can
bind.
Different subtypes for the same neurotransmitter are usually located in different areas of
the brain.
Different subtypes typically respond to the same neurotransmitter in different ways.
An advantage to having multiple receptor subtypes is that the same neurotransmitter is
able to be used to transmit multiple different messages to different parts of the brain.
o Binding of a neurotransmitter to one of its receptor subtypes can influence a post-synaptic
neuron in one of two fundamentally different ways:
Ionotropic Receptors: Receptors associated with ligand-activated ion channels.
When a neurotransmitter molecule binds to an ionotropic receptor, the associated ion
channel usually opens or closes immediately, inducing immediate post-synaptic
potential.
EPSPs occur when the neurotransmitter opens sodium channels, therby increasing the
flow of Na+ ions into the neuron.
IPSPs occur when the neurotransmitter opens potasium or chlorine channels, increasing
the flow of K+ ions out of the neuron, or the flow of Cl- into the neuron.
Less prevalent than metabotropic receptors.
Metabotropic Receptors: Receptors that are associated with signal proteins and G
Proteins.
Effects of metabotropic receptors are slower to develop, longer lasting, more diffuse and
more varied.
More prevalent than ionotropic receptors.
Many different kinds of metabotropic receptors, but each is attached to a serpentine
signal protein that winds its way back and forth through the cell membrane 7 times.
The metabotropic receptor is attached to a portion of the signal protein outside the
neuron.
The G protein is attached to a portion of the signal protein inside the neuron.
When a neurotransmitter binds to a metabotropic receptor, a subunit of the associated G
protein breaks away.
One of two things happens depending on the particular G protein:
o The subunit may move along the inside surface of the membrane and bind to a
nearby ion channel, inducing either an EPSP or IPSP
o May trigger the synthesis of a chemical called a second messenger.
o Second Messenger: A chemical synthesized in a neuron in response to the binding
of a neurotransmitter to a metabotropic receptor in the cell membrane.
Once created , a second messenger diffuses through the cytoplasm and may
influence the activities of the neuron in a variety of ways.
For example, it could enter the nucleus and bind to the DNA, thereby
influencing genetic expression.
o The binding of a neurotransmitter to a metabotropic receptor can have long-lasting
effects.
Autoreceptors: metabotropic receptors that bind to their own neuron's neurotransmitter
molecules and are located on the presynaptic, rather than the postsynaptic membrane.
o Typical function of autoreceptors is to monitor the amount of neurotransmitter
molecules in the synapse, to reduce subsequent release when the levels are high and
to increase subsequent release when te are low
G Proteins: Guanosine-triphosphate-sensitive proteins;
4.6: Neurotransmitters
Well over 100 different neurotransmitters active in the body
3 classes of conventional small-molecule neurotransmitters:
o Amino acids
o Monoamines
o Acetylcholine
The fourth class of small-molecule neurotransmitters is often referred to as unconventional
neurotransmitters because their mechanisms of action are unusual
There is only one class of large-molecule neurotransmitter:
o Neuropeptides
Most neurotransmitters produce either excitation or inhibition, but not both
o A few select neurotransmitters cause excitation upon binding to certain types of neurons (ie. in
differing areas of the brain), but inhibition when binding to others.
Amino Acid Neurotransmitters: A class of small-molecule neurotransmitters, which includes the
amino acids glutamate and GABA
o Four most widely studied amino acid neurotransmitters are:
Glutamate: The brain's most prevalent excitatory neurotransmitter, whose excessive release
causs much of the brain damage resulting from cerebral ishemia.
Aspartate: An amino acid neurotransmitter that is a constituent of many of the proteins that
we eat.
Glycine: An amino acid neurotransmitter that is a constituent of many of the proteins that
we eat.
Gamma-Aminobutryic Acid (GABA): The amino acid neurotransmitter that is synthesized
from glutamate; The most prevalent inhibitory neurotransmitter in the mammalian nervous
system, however it does have excitatory effects at some synapses.
Monoamine Neurotransmitters: Class of small-molecule neurotransmitters synthesized from a
single amino acid;
o Slightly larger than amino acid transmitters
o Effects tend to be more diffuese than amino acid transmitters
o Monoamines tend to cluster in small groups and are found, for the most part, in the brain stem.
o Neurons that use monoamines tend to have highly branched axon structures with many
variscosities (string of bead synapses) from which monoamine neurotransmitters are diffusely
released into the extracellular fluid.
o Four monoamine neurotransmitters:
Dopamine: One of the three catecholamine neurotransmitters; dopaminergetic neurons are
damaged by parkinson's disease.
Tyrosine is converted to L-dopa, which is in turn converted to dopamine.
Epinephrine: One of the three catecholamine neurotransmitters.
Neurons that release epinephrine have the enzyme required to convert dopamine to
norepinephrine as well as an additional enzyme which converts norepinephrine to
epinephrine.
Neurons that release epinephrine are called adrenergic.
Ephinephrine used to be called adrenaline until the name adrenaline was patented as a
brand name.
Norepinephrine: One of the three catelcholamine neurotransmitters.
Neurons that release norepinephrine have an extra enzyme that converts dopamine to
norepinephrine.
Neurons that release norepinephrine are called noradrenergic.
Norepinephrine used to be called noradrenaline until adrenaline was patented as a brand
name.
Serotonin: An inolamine neurotransmitter; the only member of this class of monoamine
found in the mamallian nervous system.
Brain-gut Peptides: Contains neuropeptides that were first discovered in the gut.
Opioid Peptides: Contains neuropeptides that are similar in structure to the active
ingredient of opium.
Miscellanious Peptides: All neuropeptides that do not fit into the other four groupings of
neuropeptides.
Many nicotinic receptors occur at the junctions between motor neurons and muscle fibres
Many musarinic receptors are located in the autonomic nervous system.
Nicontinic receptors are ionotropic, while muscarinic receptors are metabotropic.
Atropine: The main active ingredient in belladona; Receptor blocker that binds to
muscarinic receptors and prevents acetylcholine from binding to them.
The disruptive effects of high doses of atropine on memory was one of the earliest clues
that cholinergic mechanisms play are role in memory.
Curare: Extract of certain class of woody vines used as tips for poison darts; Receptor
blocker at cholinergic synapses but it acts on nicotinic receptors, blocking transmission at
neuromuscular junctions, paralyzing its recipients and killing them by blocking their
respiraton.
o Botox: Neurotoxin released by a bacterium often found in spoiled food; Nicotinic antagonist;
Blocks release of acetylcholine at neuromuscular junctions, making it a deadly poison.
o Pleasure and Pain: Discovery of Endogenous Opioids
In the 1970's opiate drugs such as morphine were found to bind effectively to receptors in
the brain.
These receptors were generally found in the hypothalamus and other limbic areas.
Most concentrated region of opioid receptors is located in the brain stem, near the cerebral
aqueduct connecting the third and fourth ventricles.
Microinjection of morphine into the periaquiductal grey or electrical stimulation of the same
area, produces analgesia.
Endogenous: Occurring naturally within the body
Several families of endogenous opioids have been identified.
Enkephalins: Meaning "in the head"; First endogenous opioid discovered;
All endogenous opioid neurotransmitters are neuropeptides, and their receptors are
metabotropic.
o Tremors and Insanity: Discovery of Antischizophrenic Drugs
Two drugs were found by coincidence that are not structurally related, but produce similar
patterns in behavioural changes
Neither drug appeared to be effective until the patient had been taking it for 3 weeks.
After the three weeks, patients would begin to develop parkinson's type symptoms, such
as trembling at rest.
Researchers used this evidence to make two discoveries:
Parkinson's disease is associated with the degeneration of the main dopamine pathway
Dopamine agonists (such as cocaine and amphetamines) produce temporary parkinson's
type symptoms.
These findings suggested that schitzophrenia was partly caused by excessive dopamine
activity at dopamine synapses
Antagonists to dopamine were hypothesized to be an effective solution for schitzophrenic
patients.
The one particular dopamine receptor, D2 receptor plays a key role in scitzophrenia, and it
was found that drugs that block those receptors are the most effective at relieving
schitzophrenic symptoms.